Bancel Stephane (CIK 1443340) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy MRNA (499,246 shares), Sell MRNA (147,473 shares), Sell MRNA (124,838 shares), Sell MRNA (39,891 shares), Sell MRNA (187,044 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Moderna, Inc. (MRNA) | Chief Executive Officer | Buy | 499,246 | $9.6M |
| 2026-08-07 | Moderna, Inc. (MRNA) | Chief Executive Officer | Sell | 147,473 | $8.3M |
| 2026-08-07 | Moderna, Inc. (MRNA) | Chief Executive Officer | Sell | 124,838 | $7.1M |
| 2026-08-07 | Moderna, Inc. (MRNA) | Chief Executive Officer | Sell | 39,891 | $2.3M |
| 2026-08-07 | Moderna, Inc. (MRNA) | Chief Executive Officer | Sell | 187,044 | $11.0M |
| 2026-08-07 | Moderna, Inc. (MRNA) | Chief Executive Officer | Buy | 252,469 | $4.8M |
| 2026-03-02 | Generate Biomedicines, Inc. (GENB) | Director | Buy | 724,160 | $0 |
| 2026-02-13 | Moderna, Inc. (MRNA) | Chief Executive Officer | Buy | 11,271 | $0 |
| 2026-02-13 | Moderna, Inc. (MRNA) | Chief Executive Officer | Sell | 5,450 | $228,846 |
| 2025-12-15 | Moderna, Inc. (MRNA) | Chief Executive Officer | Buy | 688,073 | $7.5M |
| 2025-03-04 | Moderna, Inc. (MRNA) | Chief Executive Officer | Buy | 102,821 | $3.2M |
| 2025-03-04 | Moderna, Inc. (MRNA) | Chief Executive Officer | Buy | 57,493 | $1.8M |
Source: SEC Form 4 filings · as of 2026-08-07